Cystic fibrosis‐related liver disease is an independent risk factor for mortality and increased health care resource utilization in hospitalized pediatric patients with cystic fibrosis-Reference-Cited by-同舟云学术

Cystic fibrosis‐related liver disease is an independent risk factor for mortality and increased health care resource utilization in hospitalized pediatric patients with cystic fibrosis

Published:2022-05-17 Issue:7 Volume:57 Page:1717-1725
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatric Pulmonology

Author:

Thavamani Aravind¹^ORCID,Umapathi Krishna K.²^ORCID,Kutney Katherine³^ORCID,Sferra Thomas J.¹^ORCID,Sankararaman Senthilkumar¹^ORCID

Affiliation:

1. Division of Pediatric Gastroenterology, Hepatology and Nutrition UH Rainbow Babies and Children's Hospital/Case Western Reserve University School of Medicine Cleveland Ohio USA

2. Division of Pediatric Cardiology Rush University Medical Center Chicago Illinois USA

3. Division of Pediatric Endocrinology UH Rainbow Babies and Children's Hospital/Case Western Reserve University School of Medicine Cleveland Ohio USA

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.25941

Reference32 articles.

1. Liver disease in patients with cystic fibrosis

2. Cystic Fibrosis-related cirrhosis

3. Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome

4. Features of Severe Liver Disease With Portal Hypertension in Patients With Cystic Fibrosis

5. Cirrhosis and other liver disease in cystic fibrosis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cystic fibrosis and fat malabsorption: Pathophysiology of the cystic fibrosis gastrointestinal tract and the impact of highly effective CFTR modulator therapy;Nutrition in Clinical Practice;2024-03

2. Prevalence and impact of psychiatric disorders on hospitalized pediatric patients with chronic pancreatitis;Pancreatology;2023-09

3. Cystic fibrosis year in review 2022;Pediatric Pulmonology;2023-08-18

4. Changes in liver biochemistry and tacrolimus levels following the introduction of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and liver transplant;Journal of Cystic Fibrosis;2023-05